Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Store-operated Ca2+ entry regulates Ca2+-activated chloride channels and eccrine sweat gland function
Axel R. Concepcion, Martin Vaeth, Larry E. Wagner II, Miriam Eckstein, Lee Hecht, Jun Yang, David Crottes, Maximilian Seidl, Hyosup P. Shin, Carl Weidinger, Scott Cameron, Stuart E. Turvey, Thomas Issekutz, Isabelle Meyts, Rodrigo S. Lacruz, Mario Cuk, David I. Yule, Stefan Feske
Axel R. Concepcion, Martin Vaeth, Larry E. Wagner II, Miriam Eckstein, Lee Hecht, Jun Yang, David Crottes, Maximilian Seidl, Hyosup P. Shin, Carl Weidinger, Scott Cameron, Stuart E. Turvey, Thomas Issekutz, Isabelle Meyts, Rodrigo S. Lacruz, Mario Cuk, David I. Yule, Stefan Feske
View: Text | PDF
Research Article Cell biology Dermatology

Store-operated Ca2+ entry regulates Ca2+-activated chloride channels and eccrine sweat gland function

  • Text
  • PDF
Abstract

Eccrine sweat glands are essential for sweating and thermoregulation in humans. Loss-of-function mutations in the Ca2+ release–activated Ca2+ (CRAC) channel genes ORAI1 and STIM1 abolish store-operated Ca2+ entry (SOCE), and patients with these CRAC channel mutations suffer from anhidrosis and hyperthermia at high ambient temperatures. Here we have shown that CRAC channel–deficient patients and mice with ectodermal tissue–specific deletion of Orai1 (Orai1K14Cre) or Stim1 and Stim2 (Stim1/2K14Cre) failed to sweat despite normal sweat gland development. SOCE was absent in agonist-stimulated sweat glands from Orai1K14Cre and Stim1/2K14Cre mice and human sweat gland cells lacking ORAI1 or STIM1 expression. In Orai1K14Cre mice, abolishment of SOCE was associated with impaired chloride secretion by primary murine sweat glands. In human sweat gland cells, SOCE mediated by ORAI1 was necessary for agonist-induced chloride secretion and activation of the Ca2+-activated chloride channel (CaCC) anoctamin 1 (ANO1, also known as TMEM16A). By contrast, expression of TMEM16A, the water channel aquaporin 5 (AQP5), and other regulators of sweat gland function was normal in the absence of SOCE. Our findings demonstrate that Ca2+ influx via store-operated CRAC channels is essential for CaCC activation, chloride secretion, and sweat production in humans and mice.

Authors

Axel R. Concepcion, Martin Vaeth, Larry E. Wagner II, Miriam Eckstein, Lee Hecht, Jun Yang, David Crottes, Maximilian Seidl, Hyosup P. Shin, Carl Weidinger, Scott Cameron, Stuart E. Turvey, Thomas Issekutz, Isabelle Meyts, Rodrigo S. Lacruz, Mario Cuk, David I. Yule, Stefan Feske

×

Figure 7

TMEM16A mediates SOCE-induced Cl– secretion in human sweat gland cells.

Options: View larger image (or click on image) Download as PowerPoint
TMEM16A mediates SOCE-induced Cl– secretion in human sweat gland cells.
...
NCL-SG3 cells were stably transduced with shBEST2, shTMEM16A, or control shRNA (shCtrl). (A) TMEM16A and BEST2 mRNA expression measured by quantitative real-time PCR and normalized to levels in shCtrl-transduced cells. GAPDH was used as a housekeeping control. Mean ± SEM of 3 independent experiments done in triplicate. (B) [Ca2+]i measurements in Fura-2–loaded NCL-SG3 cells stimulated with 1 μM ionomycin (Iono) in Ca2+-free Ringer solution followed by readdition of 1 mM Ca2+ to induce SOCE. Representative [Ca2+]i traces (left) and AUC (right) after readdition of 1 mM Ca2+ (Ca2+ influx phase). For additional details see Supplemental Methods. Bar graphs represent mean ± SEM of 3 independent experiments done in triplicate. (C and D) [Cl–]i measurements in MQAE-loaded NCL-SG3 cells analyzed by single-cell time-lapse fluorescence microscopy. Cells were stimulated with 1 μM ionomycin (Iono) to induce SOCE in buffer containing 100 mM Cl– followed by removal of extracellular Cl– to force Cl– secretion. The Ca2+ concentration in the extracellular buffer remained constant (1.8 mM) throughout the experiment. (C) [Cl–]i traces averaged from 50 cells in 1 experiment, and representative of 6–7 independent experiments. (D) Analysis of Cl– efflux rates (420–600 seconds, left), reduction in [Cl–]i (middle; calculated as the integrated area420–720s relative to baseline), and net Cl– efflux (right) after removal of extracellular Cl– at 420 seconds from data shown in C. For additional details see Figure 5E and Supplemental Methods. Data in D are mean ± SEM of 7 independent experiments for shCtrl, and 6 for both shBEST2 and shTMEM16A. Statistical analyses in A and D were performed using 1-way ANOVA followed by Bonferroni post hoc test. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts